What is NDC 63323-531?

63323-531 is the product NDC for Enoxaparin Sodium, Enoxaparin sodium 80 mg/.8mL injection, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Enoxaparin Sodium?

140 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Enoxaparin Sodium NDC 63323-531 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-531Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0531Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-531-90	6332305319063323053190	10 CELLO PACK in 1 CARTON (63323-531-90) / 1 SYRINGE in 1 CELLO PACK (63323-531-01) / .8 mL in 1 SYRINGEMarketed from Jun 18, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Enoxaparin Sodium
Generic name (nonproprietary): enoxaparin sodium
Active ingredients: Enoxaparin sodium — 80 mg/.8mL
Dosage form: Injection
Route: Subcutaneous
Labeler: Fresenius Kabi USA, LLCNDC labeler code 63323
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 020164
Marketing start: Jun 18, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Low-Molecular-Weight (Chemical structure)
Identifiers: Product ID 63323-531_53e20cb1-9e79-4c45-a5a7-62c3904df818SPL ID 53e20cb1-9e79-4c45-a5a7-62c3904df818SPL set ID 21b095d1-5ade-43e9-9114-30fbfb2331c9RxCUI 854228, 854235, 854238, 854241, 854245, 854248, 854252, 854255UNII 8NZ41MIK1O
Pharmacologic class: Low Molecular Weight Heparin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323053190 followed by a unit qualifier and the quantity

Package 63323-0531-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 4, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Enoxaparin sodium is a low molecular weight heparin (LMWH) indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness ( 1.1 ) Inpatient treatment of acute DVT with or without pulmonary embolism ( 1.2 ) Outpatient treatment of acute DVT without pulmonary embolism ( 1.2 ) Prophylaxis of ischemic complications of unstable angina and non–Q-wave myocardial infarction (MI) ( 1.3 ) Treatment of acute ST-segment elevation myocardial infarction (STEMI) managed medically or with subsequent percutaneous coronary intervention (PCI) ( 1.4 ) 1.1 Prophylaxis of D…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 63323-531

What is NDC 63323-531?: 63323-531 is the product NDC for Enoxaparin Sodium, Enoxaparin sodium 80 mg/.8mL injection, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Enoxaparin Sodium.
What is the active ingredient?: Enoxaparin sodium.
Who is the labeler?: Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Enoxaparin Sodium?: 140 other product NDCs are listed under this name. See all Enoxaparin Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Enoxaparin Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
enoxaparin sodium	Enoxaparin sodium 150 mg/mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-107	28955-0107-10
enoxaparin sodium	Enoxaparin sodium 80 mg/.8mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-104	28955-0104-10
enoxaparin sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-105	28955-0105-10
enoxaparin sodium	Enoxaparin sodium 120 mg/.8mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-106	28955-0106-10
enoxaparin sodium	Enoxaparin sodium 60 mg/.6mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-103	28955-0103-10
enoxaparin sodium	Enoxaparin sodium 30 mg/.3mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-101	28955-0101-10
enoxaparin sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Hebei Changshan Biochemical Pharmaceutical Co., Ltd.	28955-102	28955-0102-10
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Civica, Inc.	72572-280	72572-0280-10
Enoxaparin Sodium	Enoxaparin sodium 300 mg/3mL	InjectionIntravenous, Subcutaneous	BluePoint Laboratories	68001-641	68001-0641-41
Enoxaparin Sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	BluePoint Laboratories	68001-633	68001-0633-42

All 141 Enoxaparin Sodium NDCs

Other NDCs under NDA 020164

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020164
Product	Strength	Form · route	Labeler	Product NDC
Enoxaparin sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1010
Lovenoxenoxaparin sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0075-0620
Enoxaparin sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1004
Lovenoxenoxaparin sodium	Enoxaparin sodium 150 mg/mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0075-2915
Enoxaparin sodium	Enoxaparin sodium 60 mg/.6mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1006
Lovenoxenoxaparin sodium	Enoxaparin sodium 150 mg/mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0075-8025
Enoxaparin sodium	Enoxaparin sodium 80 mg/.8mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1008
Lovenoxenoxaparin sodium	Enoxaparin sodium 300 mg/3mL	InjectionIntravenous, Subcutaneous	Sanofi-Aventis U.S. LLC	0075-0626
Enoxaparin sodium	Enoxaparin sodium 120 mg/.8mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1012
Enoxaparin Sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-535
Enoxaparin Sodium	Enoxaparin sodium 30 mg/.3mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-533
Enoxaparin Sodium	Enoxaparin sodium 30 mg/.3mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-533
Lovenoxenoxaparin sodium	Enoxaparin sodium 100 mg/mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0075-8020
Enoxaparin Sodium	Enoxaparin sodium 300 mg/3mL	InjectionIntravenous, Subcutaneous	Fresenius Kabi USA, LLC	63323-539
Enoxaparin Sodium	Enoxaparin sodium 40 mg/.4mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-535
Enoxaparin Sodium	Enoxaparin sodium 150 mg/mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-537
Enoxaparin Sodium	Enoxaparin sodium 150 mg/mL	InjectionSubcutaneous	Fresenius Kabi USA, LLC	63323-537
Enoxaparin Sodium	Enoxaparin sodium 300 mg/3mL	InjectionIntravenous, Subcutaneous	Fresenius Kabi USA, LLC	63323-539
Enoxaparin sodium	Enoxaparin sodium 150 mg/mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1015
Enoxaparin sodium	Enoxaparin sodium 300 mg/3mL	InjectionSubcutaneous	Sanofi-Aventis U.S. LLC	0955-1016

Showing 20 of 38.